MARKER THERAPEUTICS INCMARKER THERAPEUTICS INCMARKER THERAPEUTICS INC

MARKER THERAPEUTICS INC

No trades
See on Supercharts

Price target

17.490.000.00%
The 1 analyst offering 1 year price forecasts for GX1 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to GX1 in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


GX1 EPS for the last quarter is −0.23 EUR despite the estimation of −0.40 EUR. In the next quarter EPS is expected to reach −0.35 EUR. Track more of MARKER THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter MARKER THERAPEUTICS INC revenue is expected to reach ‪898.14 K‬ EUR. Check out MARKER THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, GX1 price target is 17.49 EUR with a max estimate of 17.49 EUR and a min estimate of 17.49 EUR. Check if this forecast comes true in a year, meanwhile watch MARKER THERAPEUTICS INC stock price chart and keep track of the current situation with GX1 news and stock market news.